Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04288024 Completed - Clinical trials for Postural and Suprapostural Performance During Dual Tasking in Patients With Parkinson's Disease

The Learning Effects of Task-priority Strategy on Dual-task Weight Shifting and Brain Plasticity in Patients With Parkinson's Disease

Start date: February 25, 2020
Phase: N/A
Study type: Interventional

(1) postural and suprapostural performance of a dual task would be differently affected by the strategy of task prioritization and (2) the cortical activation is different according to attentional focus strategies.

NCT ID: NCT04287881 Completed - Epilepsy Clinical Trials

Methylenetetrahydrofolate Reductase Deficiency in Ischemic Stroke

Start date: October 31, 2019
Phase: N/A
Study type: Interventional

Adult onset epileptic seizures is rare and often associated with metabolic disorders, drugs and intracranial pathologies such as ischemia, hemorrhage or space-occupying lesions. Methylenetetrahydrofolate reductase (MTHFR) deficiency is one of the reasons that cause epileptic seizures in adults and can be ignored. MTHFR deficiency is an autosomal recessive disorder that results in hyperhomocysteinemia and causes a predisposition to venous and arterial thrombosis. The incidence of the polymorphism is around 40% in some countries. The aim of the retrospective study is to investigate the incidence of MTHFR deficiency in patients with adult-onset epileptic seizures.

NCT ID: NCT04287738 Completed - Alzheimer Disease Clinical Trials

Care Ecosystem: Navigating Patients and Families Through Stages of Care, Extension Trial

Start date: March 20, 2015
Phase: N/A
Study type: Interventional

This is an extension trial of a prior trial (NCT02213458). Both persons with dementia (PWD) and their caregivers were enrolled as dyads. The purpose of this randomized clinical trial is to evaluate the benefits of a program that supports model care for PWD and their caregivers. Whereas the prior trial only delivered care and examined outcomes up to 12-months, this trial extends care and outcome measurement for 5 years or until death, and includes all dyads where the caregiver reported high caregiver burden (Zarit-12 greater than or equal to 17) at pre-randomization baseline for the original trial. Participants were recruited from California, Nebraska and Iowa. Participants determined to be eligible were consented and randomized into one of two groups. Two thirds of dyads were enrolled into Navigated Care that provided them with phone-based assistance in meeting important benchmarks in their care, for example completion of legal and financial planning and strategies for minimizing caregiver burden. One third of dyads were enrolled to a control group, entitled Survey of Care. Outcomes were unchanged from the original trial except for the addition of time to long term care placement and are detailed below.

NCT ID: NCT04286230 Completed - Clinical trials for Infectious Diseases and Manifestations

Construct Validation of the BIOTICA Questionnaire

BIOTICA
Start date: February 20, 2020
Phase:
Study type: Observational

Based on barriers identified in a systematic literature search, a self-report questionnaire called "BIOTICA" has been developed by the research team to assess medication adherence barriers to oral AB. The purpose of the BIOTICA-questionnaire is to detect individual barriers that prevent the optimal intake of oral AB and thus, lead to inadequate adherence or persistence to the regimen. A study is now needed to establish construct validity. Correlation between the answers to the BIOTICA-questionnaire and the electronically monitored intake of the oral AB will be analyzed in the general population.

NCT ID: NCT04285853 Completed - Clinical trials for Anterior Cruciate Ligament Rupture

Are Opioids Needed After ACL Reconstruction

Start date: September 16, 2020
Phase: Phase 4
Study type: Interventional

As the public health sector continues to confront the opioid epidemic, orthopaedic surgeons must revisit pain management protocols to reduce unnecessary opioid prescriptions. The long-term goal is to reduce opioid use and residual opioids in circulation.

NCT ID: NCT04285723 Completed - Clinical trials for PIK3CA-Related Overgrowth Spectrum (PROS)

Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib

EPIK-P1
Start date: June 9, 2020
Phase:
Study type: Observational

The study was a site-based retrospective non-interventional medical chart review of pediatric and adult male and female patients with PIK3CA-Related Overgrowth Spectrum (PROS) who initiated alpelisib at least 24 weeks before the cut-off date at a MAP site. The study cut-off date was 09-Mar-2020. Patient-level data were abstracted from medical charts of all eligible patients at all participating sites. Study completion date refers to the last date data was extracted. Information from patients treated with alpelisib was used to describe the efficacy and safety of alpelisib in PROS patients.

NCT ID: NCT04285151 Completed - Clinical trials for Proliferative Diabetic Retinopathy

Nd:YAG Laser Hyaloidotomy for Premacular Hemorrhage in Diabetic Eyes

Start date: January 2015
Phase: N/A
Study type: Interventional

Premacular Subhyaloid hemorrhage is a sudden profound loss of vision in eyes with proliferative diabetic retinopathy (PDR). Pars plana vitrectomy is the treatment of choice for premacular hemorrhage in eyes with proliferative changes. Nd:YAG laser hyaloidotomy has been used to evacuate the premacular hemorrhage

NCT ID: NCT04284995 Completed - Clinical trials for Myocardial Infarction

A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction

CEL-02
Start date: June 2, 2020
Phase: Phase 2
Study type: Interventional

RUC-4 is a novel, promising and fast acting (5-15 minutes) αIIbβ3 receptor antagonist with a high-grade inhibition of platelet aggregation (≥80%) shortly after subcutaneous administration. This study is designed to extend the findings in CEL-01 to patients with ST-elevation myocardial Infarction (STEMI) presenting to the cardiac catheterization laboratory with planned coronary angioplasty.

NCT ID: NCT04284748 Completed - Muscle Weakness Clinical Trials

Effect of Blood Flow Restriction Training on Patient With Anterior Cruciate Ligament Reconstruction

Start date: December 10, 2018
Phase: N/A
Study type: Interventional

This study investigates the effects of plyometric training with blood flow restriction on muscular strength, quadriceps thickness and knee joint function in patients with muscle weakness and atrophy (quadriceps muscle and hamstring muscle) after anterior cruciate ligament reconstruction. Persons who completed a 12-week routine rehabilitation program after anterior cruciate ligament reconstruction will be included in the study. In the study group, plyometric exercises will be performed with blood flow restriction in the operated side for 8 weeks. In the control group, the same plyometric exercises will be performed without any application.

NCT ID: NCT04284579 Completed - Clinical trials for Movement After Intravenous Cannulation

Optimum Time for Intravenous Cannulation After Induction With Sevoflurane in Pediatric Patient

Start date: May 27, 2019
Phase: N/A
Study type: Interventional

This study aimed to determinate effective dose 95 (ED95) intravenous cannulation in pediatric patient after induction of sevoflurane 8 vol%